Document:

Exhibit 10.18

 Exhibit 10.18 
  

			
	 Edward L. Field
 1522
3rd Avenue West
 Seattle, WA 98119
	  	

 Dear Ed: 
 STEMCO Biomedical, Inc. (the “Company”) is pleased to extend an offer to you to join as Executive Vice President and Chief Operating Officer, commencing October 4, 2004. We have established
the rate for this position as $165,000 per annum, payable in accordance with the normal payroll practices of the Company beginning on the Company’s next regular payroll period following your date of employment. Subject to shareholder approval
you will receive 300,000 options for shares in the company valued at $0.20 per share under the terms of the Employee Incentive Stock Option Plan. You are eligible to receive employee benefits equivalent to those of other individuals in similar
positions with the Company. These benefits include paid holiday and vacation time off, paid sick leave, health, disability, life, dental and vision insurance, as well as a 401(k) plan. The details of these benefits are available in the STEMCO
Biomedical Employee Handbook. 
 In connection with your relocation, the Company will pay for up to three months temporary living expenses and
movement of your household goods. In addition, the Company will provide up to up to two trips from North Carolina to Seattle during your transition period. 
 While we hope this relationship will be a long lasting one, you and we understand that this is employment may be ended by either of us at any time, with or without cause. The Confidentiality and
Non-Competition Agreement, to be separately executed as attached, is incorporated in its entirety by reference herein. 
 If you are terminated
“without cause” and you execute a Release and Settlement Agreement in the form acceptable to the company, the company will pay you an amount equal to three months base salary less all applicable deductions and you will be entitled to
receive all normal Company benefits to the extent such benefits can be provided to a non-employee for the shorter of three months or until you obtain reasonably comparable coverage from another employer, “For cause” shall be defined as:

 (1) material breach of the terms of your employment or failure to diligently and property perform your duties for the Company; 
 (2) misappropriation or unauthorized use of the Company’s tangible or intangible property, or breach of the Confidentiality Agreement; 
 (3) material failure to comply with the Company Policies or any other policies and/or directives of the CEO and Board; 
 (4) use of illegal drugs or any illegal substance, or use of alcohol in any manner that materially interferes with the performance of your duties;

 (5) dishonest or illegal action or any other action whether or not dishonest or illegal which is materially detrimental to the interest,
well-being or reputation of the Company; 
 (6) failure to fully disclose any material conflict of interest you may have with the Company in a
transaction between the Company and any third party that is materially detrimental to the interest and well being of the Company; 
 (7) adverse
action or omission by you which would be required to be disclosed pursuant to public securities laws or which would limit the ability of the Company or any entity affiliated with the Company to sell securities under any Federal or state law or which
would disqualify the Company or any affiliated entity from any exemption otherwise available to it; or 

					
	Page 2	 		  	September 10, 2004

  

 (8) violation of the Company’s policies prohibiting harassment or unlawful discrimination.

 You understand and agree that a criminal background check and drug test will be conducted after an employment offer has been made by STEMCO
Biomedical. The criminal background check will reveal information on your character, general reputation, personal characteristics, or mode of living. The results of the drug test will be used solely to determine whether you are currently engaging in
the illegal use of drugs. You hereby authorize and consent to the taking a drug screening test for this purpose, to the testing of such sample, and to the release of the test results to the STEMCO Biomedical. You also understand and agree that if
employed by the Company, you will submit yourself to any future drug tests at the Company’s request, and that your failure to submit to these tests or pass these tests may result in the immediate termination of my employment. You further
understand and agree that the results of the criminal background check and drug test will be disclosed only to STEMCO Biomedical and will be treated in a confidential manner. You understand and agree that detrimental information discovered about you
on the criminal background check and/or your failure to pass the drug test will result in the immediate termination of the employment offer. 
 If you decide to accept this offer to join the Company as EVP & COO and the forgoing terms and conditions are acceptable, please sign this letter where indicated below and return it to me at your earliest convenience. I look
forward to your favorable response and to working with you to fully capitalize on the many opportunities that will make STEMCO Biomedical a worldwide leader. 
  

	
	Sincerely,
	
	 /s/ James D. Petrilla

	James D. Petrilla
	CEO
	STEMCO BIOMEDICAL, INC

 Accepted and agreed to this 10th day of September, 2004: 
  

			
	Signature:	 	 /s/ Edward L. Field

 Attachment: Confidentiality and Non-Complete AgreementExhibit 10.19

 Exhibit 10.19 
 October 12, 2000 
 Dear Andrew (“Employee”): 
 StemCo Biomedical, Inc. (the “Company”) is pleased to extend an offer to join the Company as Director, Business Development. 
 On the basis of our discussions, I have summarized below the terms of the Company’s offer to you. 
  

	1.	Compensation 

 Salary.

 Salary for this position is established at $125,000 per year, payable in accordance with the normal payroll practices of the
Company beginning on the Company’s next regular payroll period following your date of employment. 
 Stock Options. Annual
Bonus 
 Subject to shareholder approval, you will be eligible to be granted options for additional shares in the Company, under
the terms of the Employee Incentive Stock Option Plan, as annual bonus based upon your performance measured against annually established objectives, in accordance with the annual bonus plan set forth by board of directors of the Company. 

Annual Review of Performance. 
 As an Employee of the Company, you will be subject to an annual review for the determination of subsequent merit salary adjustments. 
 Paid Time Off. 
 You
will accrue paid time off at the rate of 10 hours per month, which equals 120 hours per year for full time employment. You are eligible to take paid time off after 2 months of employment. 
 Sick Leave 
 Five
(5) days sick leave will accrue to you on your first day of employment, and thereafter, five (5) days sick leave shall accrue to you annually on the first day of the Company’s fiscal year. Sick leave may be used at any time during the
fiscal year in which it accrues. Unused sick leave will not be carried forward from one fiscal year to the next. 
 Additional
Benefits. 
 You are also eligible for additional benefits equivalent to those of other individuals in similar positions with the
Company. The Company’s memorandum on employee benefits describes the benefits for which you will be eligible. 
 Start Date.

 Your first day of employment will be November 1, 2000. 

	2.	Employment-at-Will 

 While
we hope this relationship will be a long lasting one, you and we understand that this employment may be ended by either of us at any time, with or without cause. Notwithstanding the foregoing, in the event that your employment with the Company is
terminated for reasons other than for “cause” (as hereinafter defined), the Company shall pay to you an amount equivalent to six (6) months salary (“Severance Benefit”). The Severance Benefit will be calculated using your
current monthly salary as of the date of termination, and will be paid at the normal payroll dates for the Company. 
 For the
purposes of this Agreement, “cause” shall mean: 
 (i) Any material breach of the terms of any
agreement with the Company by the Employee, or the failure of the Employee to diligently and properly perform his duties for the Company; or 
 (ii) Any material failure by the Employee to comply with the reasonable policies and/or directives of the management or Board of Directors; or 
 (iii) Any action by the Employee that is illegal or not in good faith which is materially detrimental to the interest and
well-being of the Company, or 
 (iv) Any failure by the Employee to fully disclose any material conflict of
interest he may have with the Company in a transaction between the Company and any third party which is materially detrimental to the interest and well-being of the Company; or 
 (v) Any adverse act or omission by the Employee which would be required to be disclosed pursuant to public securities laws or
which would limit the ability of the Company or any entity affiliated with the Company to sell securities under any Federal or state law or which would disqualify the Company or any affiliated entity from any exemption otherwise available to it.

  

	3.	Confidentiality 

 The
Confidentiality and Non-Competition Agreement, to be separately executed as attached, is incorporated in its entirety by reference herein. 
  

	4.	Expiration of Offer 

 If
you decide to accept this offer to join the Company as Director, Business Development, please contact me so that we can discuss your start day. 
 If the foregoing terms and conditions are acceptable, please sign this letter where indicated below and return it to me at your earliest convenience. This offer expires on October 17, 2000.

 Finally, it is with great pleasure that I welcome you to StemCo Biomedical, Inc., and wish
you every success in your position. The Company is delighted with the prospect of your joining our team. 
  

			
	StemCo Biomedical Inc.
		
	By:	 	 /s/ Clay Smith

		 	Clay Smith, President

  

					
	Consented To and Agreed:
	
	 /s/ Andrew E. Balber

	Andrew E. Balber
		
	  
	 	
	Date:	 	  
	 	
		
	Enclosures

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00164-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00164-of-00352.parquet"}]]